hepatitis C

Unique clinic-pharmacy collaboration benefits hepatitis C patientsA Walgreens study sheds light on the benefits of patient-centered pharmacy-based programs.
How Pharmacists Are Helping Hep C Patients
How Pharmacists Are Helping Hep C PatientsA Walgreens study found that pharmacist collaboration helps Hep C patients with better outcomes and cheaper co-pays.
How to manage hepatitis C patients under MACRAImproved documentation and data can not only improve wellness, but also a practice’s value scores
Oral specialty drug options on the horizon
Oral specialty drug options on the horizonAs more specialty drugs are approved, cost control strategies are key.
Medical marijuana update: Top 3 things health execs should knowHere’s what you need to know about medical marijuana laws, and what they mean for the healthcare system.
Controversy surrounds Exondys 51 approval: What to knowNew medicine for Duchenne muscular dystrophy raises questions. Here’s whose covering it and why.
Evolving hepatitis C pipeline offers hope to patients
Evolving hepatitis C pipeline offers hope to patientsCost burden prompts payers to consider appropriate utilization
CDC issues advisory on Zika testingThe latest on testing guidelines for Zika from the CDC. Plus: Are corticosteroids effective when administered only hours before delivery? Also, a look at the prevalence of hepatitis C among pregnancy women in the United States.
Tripled Hep C Rates Blamed on Opioid Crisis
Tripled Hep C Rates Blamed on Opioid CrisisThe surge in HCV transmission rates is being blamed on the opioid epidemic.
Hep C drugs approved for kidsFDA approved supplemental applications for 2 primary hepatitis C medications to be used in children for the first time.